International Biotechnology Trust as of March 31, 2017
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 60 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 8.3 | $22M | 174k | 124.43 | |
Biogen Idec (BIIB) | 7.9 | $21M | 75k | 273.42 | |
Regeneron Pharmaceuticals (REGN) | 6.7 | $18M | 45k | 387.37 | |
Incyte Corporation (INCY) | 6.5 | $17M | 128k | 133.67 | |
Alexion Pharmaceuticals | 5.8 | $15M | 125k | 121.24 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 5.1 | $13M | 123k | 109.34 | |
Shire | 4.5 | $12M | 68k | 174.22 | |
Amgen (AMGN) | 4.2 | $11M | 67k | 164.07 | |
Illumina (ILMN) | 3.8 | $9.8M | 58k | 170.64 | |
Achaogen | 2.7 | $7.1M | 280k | 25.23 | |
Gilead Sciences (GILD) | 2.6 | $6.9M | 102k | 67.91 | |
BioMarin Pharmaceutical (BMRN) | 2.6 | $6.8M | 78k | 87.79 | |
Supernus Pharmaceuticals (SUPN) | 2.4 | $6.3M | 200k | 31.25 | |
Bristol Myers Squibb (BMY) | 2.0 | $5.3M | 98k | 54.38 | |
Entellus Medical Cm | 1.8 | $4.7M | 342k | 13.77 | |
Halozyme Therapeutics (HALO) | 1.8 | $4.6M | 358k | 12.95 | |
Acceleron Pharma | 1.7 | $4.5M | 171k | 26.46 | |
Kite Pharma | 1.7 | $4.3M | 56k | 78.31 | |
Seattle Genetics | 1.6 | $4.1M | 65k | 62.86 | |
Jazz Pharmaceuticals (JAZZ) | 1.5 | $3.9M | 27k | 145.11 | |
Tesaro | 1.4 | $3.6M | 24k | 153.87 | |
Dermira | 1.4 | $3.6M | 105k | 34.09 | |
Adamas Pharmaceuticals | 1.2 | $3.2M | 185k | 17.47 | |
Neuroderm Ltd F | 1.1 | $2.9M | 108k | 26.50 | |
Exelixis (EXEL) | 1.1 | $2.8M | 131k | 21.66 | |
D Stemline Therapeutics | 1.1 | $2.8M | 330k | 8.50 | |
Anaptysbio Inc Common (ANAB) | 1.1 | $2.8M | 101k | 27.75 | |
Kalvista Pharmaceuticals (KALV) | 1.0 | $2.5M | 322k | 7.81 | |
Beigene (BGNE) | 0.9 | $2.4M | 66k | 36.63 | |
Prothena (PRTA) | 0.9 | $2.3M | 42k | 55.76 | |
Global Blood Therapeutics In | 0.8 | $2.1M | 58k | 36.79 | |
Ionis Pharmaceuticals (IONS) | 0.8 | $2.1M | 52k | 40.19 | |
Vanda Pharmaceuticals (VNDA) | 0.7 | $1.9M | 136k | 13.95 | |
Neurocrine Biosciences (NBIX) | 0.7 | $1.7M | 40k | 43.29 | |
ACADIA Pharmaceuticals (ACAD) | 0.7 | $1.7M | 50k | 34.38 | |
Veracyte (VCYT) | 0.6 | $1.6M | 170k | 9.17 | |
Synergy Pharmaceuticals | 0.6 | $1.5M | 312k | 4.65 | |
Nektar Therapeutics (NKTR) | 0.5 | $1.4M | 60k | 23.47 | |
Trillium Therapeutics, Inc. Cmn | 0.5 | $1.4M | 222k | 6.15 | |
Coherus Biosciences (CHRS) | 0.5 | $1.3M | 62k | 21.10 | |
Clovis Oncology | 0.5 | $1.3M | 20k | 63.65 | |
Intercept Pharmaceuticals In | 0.5 | $1.3M | 11k | 113.13 | |
Horizon Pharma | 0.5 | $1.3M | 85k | 14.76 | |
Sage Therapeutics (SAGE) | 0.5 | $1.2M | 17k | 71.08 | |
Agios Pharmaceuticals (AGIO) | 0.5 | $1.2M | 20k | 58.40 | |
Gw Pharmaceuticals Plc ads | 0.4 | $1.1M | 9.2k | 120.98 | |
Transenterix | 0.4 | $1.1M | 889k | 1.21 | |
Calithera Biosciences | 0.4 | $1.1M | 93k | 11.55 | |
Ironwood Pharmaceuticals (IRWD) | 0.4 | $1.0M | 59k | 17.05 | |
Portola Pharmaceuticals | 0.4 | $1.0M | 26k | 39.19 | |
Macrogenics (MGNX) | 0.4 | $1.0M | 54k | 18.59 | |
Foamix Pharmaceuticals | 0.4 | $979k | 198k | 4.95 | |
Ligand Pharmaceuticals In (LGND) | 0.4 | $952k | 9.0k | 105.78 | |
Merus Nv | 0.3 | $803k | 33k | 24.26 | |
Radius Health | 0.3 | $765k | 20k | 38.64 | |
Pacira Pharmaceuticals (PCRX) | 0.3 | $729k | 16k | 45.56 | |
Array BioPharma | 0.3 | $693k | 78k | 8.94 | |
Aerie Pharmaceuticals | 0.3 | $680k | 15k | 45.33 | |
Alder Biopharmaceuticals | 0.2 | $498k | 24k | 20.75 | |
Xencor (XNCR) | 0.2 | $430k | 18k | 23.89 |